Article Details

Vascular Biogenics (VBLT) Stock Rating Upgraded by Zacks Investment Research

Retrieved on: 2019-05-17 22:46:57

Tags for this article:

Click the tags to see associated articles and topics

Vascular Biogenics (VBLT) Stock Rating Upgraded by Zacks Investment Research. View article details on hiswai:

Excerpt

<div><b>Acadian Asset Management</b> LLC boosted its position in shares of Vascular Biogenics by 272.3% in the first quarter. <b>Acadian Asset Management</b> LLC ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo